Actinium Pharmaceuticals, Inc.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signature Page
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant.
| Dated: March 31, 2025 | ACTINIUM PHARMACEUTICALS, INC. | |
|---|---|---|
| By: | /s/ Sandesh Seth | |
| Sandesh Seth | ||
| Chairman and Chief Executive Officer (Duly Authorized Officer, Principal Executive Officer) | ||
| By: | /s/ Steve O’Loughlin | |
| Steve O’Loughlin | ||
| Chief Financial Officer (Duly Authorized Officer, Principal Financial and Accounting Officer) | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following person on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Sandesh Seth | Chairman and Chief Executive Officer | March 31, 2025 |
| Sandesh Seth | (Principal Executive Officer) | |
| /s/ June Almenoff | Director | March 31, 2025 |
| June Almenoff | ||
| /s/ Jeffrey Chell | Director | March 31, 2025 |
| Jeffrey Chell | ||
| /s/ David Nicholson | Director | March 31, 2025 |
| David Nicholson | ||
| /s/ Richard I. Steinhart | Director | March 31, 2025 |
| Richard I. Steinhart | ||
| /s/ Ajit J. Shetty | Director | March 31, 2025 |
| Ajit J. Shetty | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.